BRIEF-European Medicines Agency's CHMP recommends approval for Merck's Keytruda
July 21, 2017 at 07:52 AM EDT
* European Medicines Agency's CHMP recommends approval for Merck's Keytruda® (pembrolizumab) for the treatment of certain patients with locally advanced or metastatic urothelial carcinoma, a type of bladder cancer